Form 8-K - Current report:
SEC Accession No. 0001467154-23-000109
Filing Date
2023-09-27
Accepted
2023-09-27 16:47:18
Documents
12
Period of Report
2023-09-27
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K novn-20230927.htm   iXBRL 8-K 39085
  Complete submission text file 0001467154-23-000109.txt   166753

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT novn-20230927.xsd EX-101.SCH 1895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT novn-20230927_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT novn-20230927_pre.xml EX-101.PRE 12504
6 EXTRACTED XBRL INSTANCE DOCUMENT novn-20230927_htm.xml XML 2708
Mailing Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703
Business Address 4020 STIRRUP CREEK DRIVE, SUITE 110 DURHAM NC 27703 919-485-8080
Novan, Inc. (Filer) CIK: 0001467154 (see all company filings)

EIN.: 204427682 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37880 | Film No.: 231285200
SIC: 2834 Pharmaceutical Preparations